HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenneth Vielsted Christensen Selected Research

Serotonin 5-HT1 Receptor Agonists

2/2024Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenneth Vielsted Christensen Research Topics

Disease

5Parkinson Disease (Parkinson's Disease)
02/2024 - 01/2017
2Dyskinesias (Dyskinesia)
02/2024 - 12/2022
2Disease Progression
05/2021 - 01/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020
1Hyperekplexia
01/2017
1Alzheimer Disease (Alzheimer's Disease)
04/2009

Drug/Important Bio-Agent (IBA)

2Levodopa (L Dopa)FDA LinkGeneric
02/2024 - 12/2022
2zolmitriptan (Zomig)FDA Link
02/2024 - 12/2022
2Buspirone (Buspar)FDA LinkGeneric
02/2024 - 12/2022
2Biomarkers (Surrogate Marker)IBA
05/2021 - 01/2020
2SynucleinsIBA
01/2020 - 01/2018
1Serotonin 5-HT1 Receptor AgonistsIBA
02/2024
1Serotonin (5 Hydroxytryptamine)IBA
12/2022
1Amantadine (Aman)FDA LinkGeneric
12/2022
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2017
1Leucine (L-Leucine)FDA Link
01/2017
1Phosphotransferases (Kinase)IBA
01/2017
1Proteins (Proteins, Gene)FDA Link
04/2009
1Amyloid beta-PeptidesIBA
04/2009

Therapy/Procedure

2Therapeutics
12/2022 - 05/2021